Although breast cancer patients are widely classified into the luminal A, luminal B, Her-2, and TNBC molecular subtypes in clinical practice [6, 15], these subtypes are only an approximation of the underlying genotype-based subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.